NRIX
NURIX THERAPEUTICS INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
NURIX THERAPEUTICS INC (NRIX) is held as common stock by 5 tracked hedge-fund managers, with a combined reported value of ~$194.63M; the largest are Baker Bros. Advisors, Cathie Wood, Ken Griffin. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 2 added, 2 trimmed, 1 closed. 1 public STOCK Act / OGE trade disclosures are on record. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Mixed
Common-stock holders51 also report options
Congress trades1
Price$23.67vs quarter-end-2.43%
Sectors0
This quarter's moves
Top holderBaker Bros. AdvisorsNew0
Added2
Trimmed / sold3
Common-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
Value $113.02M0.6% of portfolio4,658,5562026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Baker Bros. Advisors | $113.02M | 0.6% | Hold |
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $994.7K— of portfolio41,0002026 Q2
Value $276.6K— of portfolio11,4002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $994.7K | — | — |
| Ken GriffinPUT | $276.6K | — | — |
ARK ETF holdings
Cathie Wood · dailyARK total shares held · drag to inspect
2026-09-29holds 1,700,810
- ARKGweight in fund1.85%$40.26M
ARK publishes full ETF holdings daily (SEC Rule 6c-11). Line shows ARK's total shares held over time (not price); markers are buy/sell days. Derived from public CSVs — research only, not investment advice.
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.